To the Editor: Targeted proteomics methods such as selected reaction monitoring (SRM) and parallel reaction monitoring (PRM) are increasingly popular because they allow sensitive and rapid analysis of preselected proteins [1][2][3] . However, the development of targeted assays is tedious and typically requires selection, synthesis and mass spectrometric analysis of candidate peptides. SRMAtlas and ProteomeTools provide fragmentation spectra of synthetic peptides covering the entire human proteome 4,5 , but it is difficult to extract relevant data for specific proteins. Also, the development of scheduled acquisition methods (i.e., for the analysis of specific peptides in defined elution time windows) requires adjustments to specific chromatographic conditions. The number of peptides to be targeted in parallel often exceeds the speed of the mass spectrometer, which forces researchers to ask which peptides can be omitted without sacrificing too much information. Available method design tools do not generate optimized scheduled acquisition methods ( Supplementary  Fig. 1) .
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Picky: a simple online PRM and SRM method designer for targeted proteomics
To the Editor: Targeted proteomics methods such as selected reaction monitoring (SRM) and parallel reaction monitoring (PRM) are increasingly popular because they allow sensitive and rapid analysis of preselected proteins [1] [2] [3] . However, the development of targeted assays is tedious and typically requires selection, synthesis and mass spectrometric analysis of candidate peptides. SRMAtlas and ProteomeTools provide fragmentation spectra of synthetic peptides covering the entire human proteome 4, 5 , but it is difficult to extract relevant data for specific proteins. Also, the development of scheduled acquisition methods (i.e., for the analysis of specific peptides in defined elution time windows) requires adjustments to specific chromatographic conditions. The number of peptides to be targeted in parallel often exceeds the speed of the mass spectrometer, which forces researchers to ask which peptides can be omitted without sacrificing too much information. Available method design tools do not generate optimized scheduled acquisition methods ( Supplementary  Fig. 1) .
Here, we present Picky (https://picky.mdc-berlin.de), a fast and user-friendly online design tool for PRM and SRM assays (Fig. 1a,  Supplementary Methods) . Users simply provide identifiers for human (or mouse) proteins of interest. Picky then selects corresponding tryptic peptides and their experimentally observed retention times (RTs) from the ProteomeTools data set for targeted analysis. Picky uses a scheduling algorithm that adapts to different HPLC gradients (Supplementary Fig. 2 ), which allows users to upload a list of experimentally observed peptide RTs acquired on their HPLC system. Picky uses these data to rescale the experimentally observed RTs from ProteomeTools and thus to predict their RTs under the chromatographic conditions used. More than 80% of RTs are correctly predicted within an elution time window of ±3 min, which is a considerable improvement compared with predictions based on hydrophobicity scores (Supplementary Figs. 3-5) . Alternatively, users can directly provide experimentally observed RTs of target peptides (Supplementary Methods). The acquisition list is further optimized if the number of peptides monitored in parallel exceeds a user-defined threshold. In this case, the lowest-scoring peptide from the protein with the greatest number of targeted peptides is removed in an iterative manner (Supplementary Fig. 2) . Hence, Picky selects the best set of peptides covering the targeted proteins under the given chromatographic constraints. For SRM, Picky selects transitions based on the most intense fragment ions observed. Options such as isotope labels, fragmentation types and protein-abundance-specific SRM dwell times (Supplementary Fig. 6 ) can be freely adjusted by the user. The tool exports an inclusion list, which can be imported into the acquisition software of different mass spectrometers. Picky also displays annotated fragmentation spectra and exports the corresponding spectral library. This library can be imported into Skyline 6 to validate the acquired SRM/PRM data.
To assess the performance of PRM assays designed by Picky, we spiked different amounts of standard human proteins into 1.4 µg of yeast extract (Supplementary Methods). We provided Picky with (i) identifiers of target human proteins and (ii) an RT calibration file obtained through measurement of the yeast digest alone. On the basis of this input, Picky designed an optimized PRM method in less than a minute. We then used this method to analyze the reference samples by PRM and by standard data-dependent acquisition (DDA) for comparison. PRM markedly outperformed DDA at higher dilutions of the spiked-in proteins (Fig. 1b) . We also targeted the same number of randomly selected human proteins and did not observe a single false-positive hit. Thus, Picky enables the detection of human proteins with high sensitivity and specificity.
SRM/PRM data are typically validated by monitoring of the chromatographic coelution of multiple transitions for a given peptide 6 . In our experiment, this yielded convincing profiles for high amounts of spiked-in proteins but somewhat unclear results for lower amounts (Supplementary Fig. 7) . We therefore compared the PRM data to the fragmentation spectra of corresponding synthetic peptides exported by Picky. The high similarity between the spectra (normalized spectral contrast angle ≥ 0.5) validated the PRM data ( Supplementary  Fig. 8) . We also compared all acquired spectra derived from the UPS1 universal proteomics standard with all fragmentation spectra in the Picky database (Supplementary Fig. 9 ). We did not observe a single false match with at least five transitions. Thus Picky enables targeted protein identification with high confidence. In summary, Picky (i) automatically generates optimized scheduled SRM/PRM assays for proteins of interest and (ii) provides a means to validate the data via known fragmentation spectra of corresponding synthetic peptides. Picky thus should greatly facilitate targeted analysis of the human (and mouse) proteome.
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Experimental design 1. Sample size
Describe how sample size was determined.
The data shown illustrates technical performance of the applied algorithms. No initial sample size calculation was performed. For the sensitivity benchmark one sample for each concentration is supposed to be sufficient since we rely on a set of more than 100 peptides to judge on the performance of Picky. Alltogether four different concentrations were analyzed and reproducibility of identified peptides among these samples was shown. For the RT benchmark experiment three technical replicates were chosen, which represent a common number of repeated measurements in shotgun mass spectrometry. Further all replicates showed very similar results and are very comparable to previous independent test runs not included in this publication.
Data exclusions
Describe any data exclusions.
The PRM benchmark experiment was performed twice with very similar results. Only the result of the first experiment is shown, since identifications based on carry-over effects in the second run cannot be ruled out.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
The PRM benchmark experiment was performed twice with very similar results. Only the result of the first experiment is shown, since identifications based on carry-over effects in the second run cannot be ruled out. The RT benchmark experiments ran twice with very different settings. The runs were repeated based on a request of a reviewer. The first run was calibrated on a human sample, while the second run was calibrated on a biologically indepent (E.coli) sample. Nevertheless the results from both experiments were identical, prooving the reproducibility of our findings.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
The data illustrate the functionality of the applied algorithms. All differences were technically introduced (spike in at different concentrations) and do not require randomization. Benchmarks were analyzed in increasing order of the spike in. A randomization would have lead to wrong conclusions from the data, caused by carry over from higher concentrated samples to lower ones.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was not applicable during data collection. The used benchmark samples are a dataset with artificially introduced differences (UPS1 spike-in). Blinding of the samples would have led to uncontrolled carry-over from one sample to the other. That is why the sample were analyzed with increasing amounts of UPS1 spike-in.
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
nature research | life sciences reporting summary November 2017 6. Statistical parameters For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.) A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials 8. Materials availability Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
We are not aware of restrictions on availability of the used materials.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species). 
Description of research animals
Provide all relevant details on animals and/or animal-derived materials used in the study.
No animals were used in the study.
